| __timestamp | ACADIA Pharmaceuticals Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 305409000 |
| Thursday, January 1, 2015 | 90804000 | 377080000 |
| Friday, January 1, 2016 | 186456000 | 432829000 |
| Sunday, January 1, 2017 | 255062000 | 496079000 |
| Monday, January 1, 2018 | 265758000 | 557616000 |
| Tuesday, January 1, 2019 | 325638000 | 658498000 |
| Wednesday, January 1, 2020 | 388661000 | 770456000 |
| Friday, January 1, 2021 | 396028000 | 840100000 |
| Saturday, January 1, 2022 | 369090000 | 944700000 |
| Sunday, January 1, 2023 | 402466000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding spending patterns is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated and ACADIA Pharmaceuticals Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Vertex's SG&A expenses surged by approximately 270%, reaching over $1.1 billion in 2023. In contrast, ACADIA's expenses grew by about 1,130%, peaking at around $402 million in the same year. This stark difference highlights Vertex's aggressive expansion strategy, while ACADIA's growth, though significant, remains more conservative. The data reveals a consistent upward trajectory for both companies, with Vertex maintaining a higher expenditure throughout. These insights provide a window into the strategic priorities of these pharmaceutical giants, reflecting their commitment to innovation and market presence.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs ACADIA Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Revenue Insights: Vertex Pharmaceuticals Incorporated and ACADIA Pharmaceuticals Inc. Performance Compared
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Breaking Down SG&A Expenses: Pharming Group N.V. vs ACADIA Pharmaceuticals Inc.
Perrigo Company plc or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: ACADIA Pharmaceuticals Inc. vs Iovance Biotherapeutics, Inc.